ROBERT ORTIZ: Open Payments
NPI 1851430383 · DOTHAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,164 in 70 payments from 25 companies in 2025. Trend: 2023 $2,011 · 2024 $2,163 · 2025 $1,164
Food & beverage: $1,164
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $191 |
| Amgen Inc. | 12 | $139 |
| Abbott Laboratories | 6 | $105 |
| AstraZeneca Pharmaceuticals LP | 5 | $92 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $71 |
| Neurocrine BioSciences, Inc. | 3 | $60 |
| Medtronic, Inc. | 1 | $59 |
| Merck Sharp & Dohme LLC | 3 | $52 |
| PFIZER INC. | 3 | $49 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $37 |
Products named: FREESTYLE LIBRE 3, Wegovy, REPATHA, AIRSUPRA, Kerendia, INGREZZA, SYMPLICITY G3, EVENITY.
Industry payments across AL — which companies pay providers there.
